Tearsheet

Lemonade (LMND)

Market Price (9/18/2025): $56.54 | Market Cap: $4.2 Bil
Sector: Financials | Industry: Property & Casualty Insurance

Lemonade (LMND)

Market Price (9/18/2025): $56.54
Market Cap: $4.2 Bil
Sector: Financials
Industry: Property & Casualty Insurance

Investment Highlights

0	Cash is significant % of market cap Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -13%	Stock price has recently run up significantly 12M Rtn12 month market price return is 207%
1	Strong revenue growth Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 28%	Not cash flow generative CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -1.9%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -3.6%
2		Yield minus risk free rate is negative ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -9.5%
3		Significant short interest Short Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 24%

0	Cash is significant % of market cap Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -13%
1	Strong revenue growth Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 28%
2	Stock price has recently run up significantly 12M Rtn12 month market price return is 207%
3	Not cash flow generative CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -1.9%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -3.6%
4	Yield minus risk free rate is negative ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -9.5%
5	Significant short interest Short Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 24%

Market Valuation

	9/18/25	2024	2023	2022	2021
Share Price CYE	$56.54	$36.68	$16.13	$13.68	$42.11
Market Cap CYE ($ Bil)	4.2	2.6	1.1	0.9	2.6
Total Debt ($ Bil)	0.1	0.1	0.0	0.0	0.0
Total Cash ($ Bil)	0.4	0.4	0.3	0.3	0.3
Enterprise Value ($ Bil)	3.9	2.7	1.1	0.9	2.6
Valuation Ratios
P/S TTM	6.9	5.0	2.6	3.5	20.1
P/EBIT TTM	0.0	0.0	0.0	0.0	0.0
P/E TTM	-20.4	-12.9	-4.7	-3.0	-10.7
Sector Ratios
P/S TTM (Sector)	3.2	3.1	2.8	2.8	3.4
P/EBIT TTM (Sector)	6.8	6.8	7.1	7.1	7.0
P/E TTM (Sector)	12.8	11.6	10.2	9.4	10.0

	9/18/25	2024	2023
Share Price CYE	$56.54	$36.68	$16.13
Market Cap CYE ($ Bil)	4.2	2.6	1.1
Total Debt ($ Bil)	0.1	0.1	0.0
Total Cash ($ Bil)	0.4	0.4	0.3
Enterprise Value ($ Bil)	3.9	2.7	1.1
Valuation Ratios
P/S TTM	6.9	5.0	2.6
P/EBIT TTM	0.0	0.0	0.0
P/E TTM	-20.4	-12.9	-4.7
Sector Ratios
P/S TTM (Sector)	3.2	3.1	2.8
P/EBIT TTM (Sector)	6.8	6.8	7.1
P/E TTM (Sector)	12.8	11.6	10.2

Stock Price
Market Cap

Stock Price Chart

Return (1Y):

Market Cap Chart

Business Description

Lemonade, Inc. provides various insurance products in the United States and Europe. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property. Show more

Price Returns Compared

Expand for Detailed View

	2020	2021	2022	2023	2024	2025	Total [1]
Returns
LMND Return	-	-66%	-68%	18%	127%	52%	-57%
Peers Return	6%	20%	32%	8%	40%	4%	163%
S&P 500 Return	16%	27%	-19%	24%	23%	12%	104%

[1] Cumulative total returns since the beginning of 2020
[2] Peers: PGR, MET, UNM, CB, TRV.
[3] 2025 data is for the year up to 9/17/2025 (YTD)

Better Bets than Lemonade (LMND)

	LMND	Better Performance than LMND
Metric	Value	Industry (Property & Casualty Insurance)
Rev Chg LTM	27.5%	PLMR (52.3%), ROOT (59.8%), HIPO (43.1%), BOW (41.2%), SLDE (47.5%)
Rev Chg 3Y Avg	56.5%	WTM (95.8%), ROOT (78.9%), HIPO (60.1%), ACIC (233.8%)
CFO/Rev LTM	-1.9%	PGR (20.4%), CB (24.3%), TRV (20.1%), ALL (13.2%), HIG (21.4%)
FCF/Rev LTM	-3.6%	PGR (20.0%), CB (24.3%), TRV (20.1%), ALL (12.9%), HIG (20.9%)
Total Yield	-5.0%	PGR (9.3%), CB (9.8%), TRV (9.2%), ALL (13.1%), HIG (10.3%)

	LMND	Better Performance than LMND
Metric	Value	Sector (Financials)
Rev Chg LTM	27.5%	BX (34.9%), HOOD (59.6%), COIN (75.2%), ARES (49.9%), SOFI (31.5%)
Rev Chg 3Y Avg	56.5%	APO (129.8%), NU (70.1%), BNT (81.2%), NLY (104.9%), AGNC (161.9%)
CFO/Rev LTM	-1.9%	BRK-B (6.9%), V (60.4%), MA (53.3%), BAC (4.4%), AXP (19.1%)
FCF/Rev LTM	-3.6%	BRK-B (2.1%), V (56.8%), MA (49.2%), BAC (4.4%), AXP (16.2%)
Total Yield	-5.0%	BRK-B (5.9%), JPM (6.5%), V (3.7%), MA (2.4%), BAC (7.1%)

	LMND	Better Performance than LMND
Metric	Value	All Other Sectors
Rev Chg LTM	27.5%	NVDA (71.6%), AVGO (28.0%), LLY (36.8%), PLTR (38.8%), APP (48.2%)
Rev Chg 3Y Avg	56.5%	NVDA (92.0%), RCL (65.4%), CCL (81.1%), CRDO (74.4%), SMCI (64.7%)
CFO/Rev LTM	-1.9%	NVDA (46.6%), MSFT (48.3%), AAPL (26.6%), GOOGL (36.0%), AMZN (18.1%)
FCF/Rev LTM	-3.6%	NVDA (43.6%), MSFT (25.4%), AAPL (23.5%), GOOGL (18.0%), AMZN (2.0%)
Total Yield	-5.0%	NVDA (2.1%), MSFT (3.3%), AAPL (3.2%), GOOGL (4.1%), AMZN (2.9%)

Latest Trefis Analyses

	Title	Topic
0	DASHBOARDS
1	Why Lemonade Stock Moved: LMND Stock Has Gained 314% Since 2022 Fiscal End, Primarily Due To Favorable Change In Revenues
2	Lemonade (LMND) Valuation Ratios Comparison	Financials
3	LMND Dip Buy Analysis
4	Lemonade (LMND) Stock: 40% of days in last 3 months had 1% or greater fluctuation
5	Lemonade Total Shareholder Return (TSR): 127.4% in 2024 and -4.5% 3-yr compounded annual returns (below peer average)
6	LMND Leaps 7.8% In One Day, Time To Buy The Stock?	Buy or Fear
7	Lemonade (LMND) Operating Cash Flow Comparison	Financials
8	Lemonade (LMND) Net Income Comparison	Financials

	Title
0	ARTICLES
1	Why Lemonade Stock Moved: LMND Stock Has Gained 314% Since 2022 Fiscal End, Primarily Due To Favorable Change In Revenues
2	Lemonade (LMND) Valuation Ratios Comparison
3	LMND Dip Buy Analysis
4	Lemonade (LMND) Stock: 40% of days in last 3 months had 1% or greater fluctuation
5	Lemonade Total Shareholder Return (TSR): 127.4% in 2024 and -4.5% 3-yr compounded annual returns (below peer average)
6	LMND Leaps 7.8% In One Day, Time To Buy The Stock?
7	Lemonade (LMND) Operating Cash Flow Comparison
8	Lemonade (LMND) Net Income Comparison

Recent Active Movers

1 Day Top Gainers

#	Ticker	Company	1D Rtn	YTD Rtn
1	ECDA	ECD Automotive Design	3937.1%	307.9%
2	ATHA	Athira Pharma	890.3%	544.3%
3	SPRC	SciSparc	142.9%	1141.7%
4	ATCH	AtlasClear	87.4%	-83.1%
5	GV	Visionary	68.2%	14.8%
6	APLM	Apollomics	51.3%	89.1%
7	SQFT	Presidio Property Trust	46.3%	11.0%
8	CDT	CDT Equity	40.1%	-99.1%
9	EDUC	Educational Development	31.8%	9.1%
10	ILLR	Triller	29.8%	-37.8%

1 Day Top Losers

#	Ticker	Company	1D Rtn	YTD Rtn
1	CURX	Curanex Pharmaceuticals	-83.5%	148.4%
2	CODX	Co-Diagnostics	-34.7%	-44.4%
3	BOXL	Boxlight	-34.5%	-13.5%
4	OPI	Office Properties Income Trust	-31.8%	-40.9%
5	BIAF	bioAffinity Technologies	-30.0%	-79.9%
6	ENVB	Enveric Biosciences	-29.3%	-88.0%
7	KAVL	Kaival Brands Innovations	-27.3%	-46.7%
8	AEI	Alset	-25.5%	211.8%
9	INBS	Intelligent Bio Solutions	-25.0%	0.7%
10	LVRO	Lavoro	-23.0%	-67.2%

1 Week Top Gainers

#	Ticker	Company	1W Rtn	YTD Rtn
1	ECDA	ECD Automotive Design	3347.2%	307.9%
2	BDSX	Biodesix	1090.6%	-79.7%
3	CLSD	Clearside Biomedical	987.7%	-74.7%
4	ATHA	Athira Pharma	892.1%	544.3%
5	SDOT	Sadot	690.6%	-79.9%
6	ATCH	AtlasClear	684.9%	-83.1%
7	HSDT	Helius Medical Technologies	232.1%	-95.5%
8	CHEK	Check-Cap	222.2%	134.4%
9	APLM	Apollomics	197.8%	89.1%
10	SPRC	SciSparc	147.0%	1141.7%

1 Week Top Losers

#	Ticker	Company	1W Rtn	YTD Rtn
1	CURX	Curanex Pharmaceuticals	-80.5%	148.4%
2	ATYR	aTyr Pharma	-80.4%	-71.7%
3	NAKA	Kindly MD	-70.2%
4	BNGO	Bionano Genomics	-64.0%	-89.8%
5	XAGE	Longevity Health	-57.6%	-86.1%
6	FAAS	DigiAsia	-55.4%	-88.0%
7	ASST	Strive	-54.5%	650.3%
8	VCIG	VCI Global	-51.0%	-98.9%
9	REX	REX American Resources	-50.7%	44.3%
10	RBNE	Robin Energy	-42.6%

1 Month Top Gainers

#	Ticker	Company	1M Rtn	YTD Rtn
1	PMI	Picard Medical	11931.7%	11931.7%
2	GIBO	GIBO	10714.0%
3	LNZA	LanzaTech Global	8455.2%	-86.3%
4	GTI	Graphjet Technology	3998.4%	-93.1%
5	GWAV	Greenwave Technology Solutions	3582.8%	-91.4%
6	QMMM	QMMM	3409.6%	8153.1%
7	ECDA	ECD Automotive Design	2715.2%	307.9%
8	OESX	Orion Energy Systems	1373.7%	14.2%
9	OP	OceanPal	1266.5%	-95.6%
10	BCTX	BriaCell Therapeutics	1032.4%	-89.8%

1 Month Top Losers

#	Ticker	Company	1M Rtn	YTD Rtn
1	CJET	Chijet Motor	-94.5%	-96.0%
2	STFS	Star Fashion Culture	-92.3%	-97.9%
3	ELPW	Elong Power	-91.1%	-76.9%
4	NXTT	Next Technology	-90.1%	-95.4%
5	EPIX	ESSA Pharma	-89.4%	-8.9%
6	NAKA	Kindly MD	-88.1%
7	BINI	Bollinger Innovations	-87.6%	-100.0%
8	JEM	707 Cayman	-87.4%	-98.2%
9	YAAS	Youxin Technology	-83.3%	-98.4%
10	NEON	Neonode	-82.5%	-51.0%

Recent Active Movers

1 Day Top Gainers

#	Ticker	Company	1D Rtn	YTD Rtn
1	ECDA	ECD Automotive Design	3937.1%	307.9%
2	ATHA	Athira Pharma	890.3%	544.3%
3	SPRC	SciSparc	142.9%	1141.7%
4	ATCH	AtlasClear	87.4%	-83.1%
5	GV	Visionary	68.2%	14.8%
6	APLM	Apollomics	51.3%	89.1%
7	SQFT	Presidio Property Trust	46.3%	11.0%
8	CDT	CDT Equity	40.1%	-99.1%
9	EDUC	Educational Development	31.8%	9.1%
10	ILLR	Triller	29.8%	-37.8%

1 Day Top Losers

#	Ticker	Company	1D Rtn	YTD Rtn
1	CURX	Curanex Pharmaceuticals	-83.5%	148.4%
2	CODX	Co-Diagnostics	-34.7%	-44.4%
3	BOXL	Boxlight	-34.5%	-13.5%
4	OPI	Office Properties Income Trust	-31.8%	-40.9%
5	BIAF	bioAffinity Technologies	-30.0%	-79.9%
6	ENVB	Enveric Biosciences	-29.3%	-88.0%
7	KAVL	Kaival Brands Innovations	-27.3%	-46.7%
8	AEI	Alset	-25.5%	211.8%
9	INBS	Intelligent Bio Solutions	-25.0%	0.7%
10	LVRO	Lavoro	-23.0%	-67.2%

1 Week Top Gainers

#	Ticker	Company	1W Rtn	YTD Rtn
1	ECDA	ECD Automotive Design	3347.2%	307.9%
2	BDSX	Biodesix	1090.6%	-79.7%
3	CLSD	Clearside Biomedical	987.7%	-74.7%
4	ATHA	Athira Pharma	892.1%	544.3%
5	SDOT	Sadot	690.6%	-79.9%
6	ATCH	AtlasClear	684.9%	-83.1%
7	HSDT	Helius Medical Technologies	232.1%	-95.5%
8	CHEK	Check-Cap	222.2%	134.4%
9	APLM	Apollomics	197.8%	89.1%
10	SPRC	SciSparc	147.0%	1141.7%

1 Week Top Losers

#	Ticker	Company	1W Rtn	YTD Rtn
1	CURX	Curanex Pharmaceuticals	-80.5%	148.4%
2	ATYR	aTyr Pharma	-80.4%	-71.7%
3	NAKA	Kindly MD	-70.2%
4	BNGO	Bionano Genomics	-64.0%	-89.8%
5	XAGE	Longevity Health	-57.6%	-86.1%
6	FAAS	DigiAsia	-55.4%	-88.0%
7	ASST	Strive	-54.5%	650.3%
8	VCIG	VCI Global	-51.0%	-98.9%
9	REX	REX American Resources	-50.7%	44.3%
10	RBNE	Robin Energy	-42.6%

Peer Comparisons for Lemonade

Financials

	LMND	PGR	MET	UNM	CB	TRV	Median
Name	Lemonade	Progress.	MetLife	Unum	Chubb	Traveler.
Mkt Price	55.81	243.61	78.68	75.10	272.25	275.03	161.15
Mkt Cap	4.1	142.8	52.8	13.1	108.9	62.1	57.5
Rev LTM	601	82,376	72,078	12,828	57,660	47,843	52,752
Op Inc LTM	-	-	-	-	-	-	-
FCF LTM	-21	16,472	15,229	1,444	14,000	9,633	11,816
FCF 3Y Avg	-95	12,350	13,793	1,223	13,341	8,101	10,225
CFO LTM	-12	16,800	15,229	1,577	14,000	9,633	11,816
CFO 3Y Avg	-85	12,634	13,793	1,351	13,341	8,101	10,368

Growth & Margins

	LMND	PGR	MET	UNM	CB	TRV	Median
Name	Lemonade	Progress.	MetLife	Unum	Chubb	Traveler.
Rev Chg LTM	27.5%	21.5%	5.9%	2.0%	6.8%	8.5%	7.7%
Rev Chg 3Y Avg	56.5%	20.0%	6.0%	2.9%	12.5%	10.2%	11.4%
Rev Chg Q	34.5%	21.3%	-1.8%	4.4%	6.9%	7.4%	7.2%
QoQ Delta Rev Chg LTM	7.5%	4.9%	-0.4%	1.1%	1.7%	1.8%	1.7%
Op Mgn LTM	-	-	-	-	-	-	-
Op Mgn 3Y Avg	-	-	-	-	-	-	-
QoQ Delta Op Mgn LTM	-	-	-	-	-	-	-
CFO/Rev LTM	-1.9%	20.4%	21.1%	12.3%	24.3%	20.1%	20.3%
CFO/Rev 3Y Avg	-21.7%	18.0%	19.7%	10.8%	25.2%	18.5%	18.2%
FCF/Rev LTM	-3.6%	20.0%	21.1%	11.3%	24.3%	20.1%	20.1%
FCF/Rev 3Y Avg	-23.8%	17.6%	19.7%	9.8%	25.2%	18.5%	18.0%

Valuation

	LMND	PGR	MET	UNM	CB	TRV	Median
Name	Lemonade	Progress.	MetLife	Unum	Chubb	Traveler.
Mkt Cap	4.1	142.8	52.8	13.1	108.9	62.1	57.5
P/S	6.8	1.7	0.7	1.0	1.9	1.3	1.5
P/EBIT	-	10.6	7.8	6.1	8.9	9.0	8.9
P/E	-20.1	13.7	12.3	8.6	11.8	11.8	11.8
P/CFO	-353.3	8.5	3.5	8.3	7.8	6.4	7.1
Total Yield	-5.0%	9.3%	11.0%	14.0%	9.8%	9.2%	9.6%
Dividend Yield	0.0%	2.0%	2.9%	2.3%	1.3%	0.8%	1.7%
FCF Yield 3Y Avg	-7.7%	10.3%	28.1%	11.2%	13.5%	16.6%	12.3%
D/E	0.0	0.0	0.4	0.3	0.1	0.1	0.1
Net D/E	-0.1	-0.0	-1.8	-2.7	-0.2	-1.4	-0.8

Returns

	LMND	PGR	MET	UNM	CB	TRV	Median
Name	Lemonade	Progress.	MetLife	Unum	Chubb	Traveler.
1M Rtn	-6.6%	-1.4%	1.2%	9.5%	0.1%	4.2%	0.7%
3M Rtn	37.8%	-6.4%	0.9%	-3.7%	-3.2%	4.2%	-1.1%
6M Rtn	60.9%	-10.8%	-3.8%	-6.7%	-7.5%	6.1%	-5.2%
12M Rtn	207.0%	-3.3%	3.4%	36.3%	-5.1%	15.7%	9.6%
3Y Rtn	143.2%	100.9%	32.6%	104.3%	50.3%	79.5%	90.2%
1M Excs Rtn	-8.9%	-3.8%	-1.1%	7.2%	-2.2%	1.9%	-1.7%
3M Excs Rtn	37.0%	-18.7%	-8.5%	-13.3%	-14.1%	-5.9%	-10.9%
6M Excs Rtn	46.8%	-31.5%	-19.7%	-23.7%	-24.8%	-11.1%	-21.7%
12M Excs Rtn	188.7%	-20.0%	-11.1%	22.4%	-21.8%	0.2%	-5.4%
3Y Excs Rtn	60.6%	33.8%	-34.6%	43.9%	-15.5%	15.7%	24.7%

Financials

Annual
Quarterly

$ Mil \| FY: 12/31	LTM	2024	2023	2022	2021	2020	2019
Period End	6/30/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Filing Date	8/5/2025	2/26/2025	2/28/2024	3/3/2023	3/1/2022	3/8/2021	7/2/2020
Key Financials
Total Revenue	601	526	430	257	128	94	67
Net Income	-204	-202	-237	-298	-241	-122	-108
EPS	-2.82	-2.85	-3.40	-4.59	-3.94	-3.63	-2.49
Growth Rates
Total Revenue Growth	27.5%	22.5%	67.4%	99.9%	36.0%	40.3%	199.1%
Net Income Growth	2.1%	14.6%	20.4%	-23.4%	-97.3%	-12.7%	-105.1%
Margins
Net Income Margin	-34.0%	-38.4%	-55.1%	-116.0%	-187.9%	-129.6%	-161.2%
Cash & Debt
Total Cash	670	1,011	938	1,033	1,072	577	331
Total Debt	144	107	43	35	22	0	0
Net Debt / (Cash)	-527	-904	-895	-997	-1,050	-577	-331
Cash Flows
Net Cash from Operations	-12	-11	-119	-163	-145	-92	-78
Free Cash from Operations	-21	-21	-128	-173	-154	-96	-81
Returns to Shareholders
Dividends	0	-0	-0	-0	-0	-0	-0
Share Repurchases	-0	-0	-0	-0	-0	-0	-0

$ Mil \| FY: 12/31	2025Q2	2025Q1	2024Q4	2024Q3	2024Q2	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3
Period End	6/30/2025	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Filing Date	8/5/2025	5/6/2025	2/26/2025	10/31/2024	7/31/2024	5/1/2024	2/28/2024	11/3/2023	8/4/2023	5/5/2023	3/3/2023	11/9/2022
Key Financials Quarterly
Total Revenue	164	151	149	137	122	119	116	114	105	95	88	74
Net Income	-44	-62	-30	-68	-57	-47	-42	-62	-67	-66	-64	-91
EPS	-0.60	-0.86	-0.41	-0.95	-0.81	-0.67	-0.60	-0.88	-0.97	-0.95	-0.90	-1.37
Key Financials TTM
Total Revenue TTM	601	559	526	493	471	454	430	403	362	308	257	209
Net Income TTM	-204	-217	-202	-215	-208	-218	-237	-258	-288	-289	-298	-304
Growth Rates Quarterly
Total Revenue Growth	34.5%	27.0%	28.8%	19.3%	16.6%	25.1%	30.7%	54.7%	109.2%	114.9%	115.6%	107.3%
Net Income Growth	23.3%	-31.9%	29.2%	-10.1%	14.9%	28.1%	33.4%	32.7%	1.0%	12.0%	9.4%	-37.7%
Margins Quarterly
Net Income Margin	-26.8%	-41.3%	-20.2%	-49.6%	-46.9%	-39.7%	-36.7%	-53.7%	-64.2%	-69.1%	-72.1%	-123.5%
Cash & Debt
Total Cash	670	640	1,011	585	924	921	938	558	560	988	1,033	1,058
Total Debt	144	124	107	89	67	54	43	37	32	34	35	37
Net Debt / (Cash)	-527	-516	-904	-496	-857	-866	-895	-521	-529	-954	-997	-1,021
Cash Flows Quarterly
FCF from Operations	6	-47	14	16	-12	-30	-16	-6	-50	-46	-29	-55
Cash Flows TTM
FCF from Operations TTM	-12	-29	-11	-41	-64	-102	-119	-132	-180	-170	-163	-184
Returns to Shareholders Quarterly
Dividends	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Return on Invested Capital (ROIC) Quarterly
ROIC	-12.1%	-17.7%	-12.1%	-19.3%	-22.5%	-19.0%	-17.4%	-18.9%	-21.3%	-32.6%	-34.9%	-52.3%
Return on Invested Capital (ROIC) TTM
ROIC TTM	-14.5%	-15.6%	-20.5%	-15.1%	-20.4%	-22.0%	-25.2%	-20.5%	-23.3%	-36.2%	-40.4%	-43.3%

Price Behavior

Behavior Stats
Betas Matrix

Price Behavior

Market Price	$55.81
Market Cap ($ Bil)	4.1
First Trading Date	07/02/2020
Distance from 52W High	-6.6%
	50 Days	200 Days
DMA Price	$48.18	$38.74
DMA Trend	up	up
Distance from DMA	15.8%	44.1%
	3M	1YR
Volatility	88.2%	89.6%
Downside Capture	-67.80	155.48
Upside Capture	143.23	243.37
Correlation (SPY)	10.6%	40.8%

LMND Betas & Captures as of 8/31/2025

	1M	2M	3M	6M	1Y	3Y
Beta	1.09	1.21	1.94	1.88	1.82	2.00
Up Beta	0.99	2.10	3.42	1.89	1.99	1.92
Down Beta	1.42	0.09	2.74	2.06	1.52	1.43
Up Capture	378%	208%	257%	285%	546%	4615%
Bmk +ve Days	10	22	35	71	142	415
Stock +ve Days	12	21	33	63	124	354
Down Capture	-212%	38%	-27%	140%	126%	109%
Bmk -ve Days	11	19	27	54	106	334
Stock -ve Days	9	20	29	60	121	392

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date	8292025
Short Interest: Shares Quantity	17,304,149
Short Interest: % Change Since 8152025	2.3%
Average Daily Volume	2,091,629
Days-to-Cover Short Interest	8.27
Basic Shares Quantity	73,433,379
Short % of Basic Shares	23.6%

Earnings Returns History

Expand for More

	Forward Returns
Earnings Date	1D Returns	5D Returns	21D Returns
8/5/2025	6.6%	13.9%	5.8%
5/6/2025	1.0%	6.6%	19.5%
2/25/2025	-1.6%	16.6%	7.2%
10/30/2024	26.8%	56.2%	176.3%
7/30/2024	-20.3%	-31.4%	-21.9%
2/27/2024	-27.7%	-24.8%	-25.0%
11/1/2023	47.0%	45.5%	66.4%
8/2/2023	-21.6%	-29.1%	-37.7%
...
SUMMARY STATS
# Positive	9	12	10
# Negative	11	8	10
Median Positive	6.6%	15.3%	28.4%
Median Negative	-6.7%	-12.2%	-19.7%
Max Positive	47.0%	56.2%	176.3%
Max Negative	-27.7%	-31.4%	-37.7%

	Forward Returns
8/5/2025	6.6%	13.9%	5.8%
5/6/2025	1.0%	6.6%	19.5%
2/25/2025	-1.6%	16.6%	7.2%
10/30/2024	26.8%	56.2%	176.3%
7/30/2024	-20.3%	-31.4%	-21.9%
2/27/2024	-27.7%	-24.8%	-25.0%
11/1/2023	47.0%	45.5%	66.4%
8/2/2023	-21.6%	-29.1%	-37.7%
5/3/2023	27.8%	45.2%	64.1%
2/22/2023	3.2%	-7.4%	-22.4%
11/8/2022	-4.0%	20.1%	-6.0%
8/8/2022	11.9%	23.0%	-5.2%
5/9/2022	2.4%	4.5%	11.3%
2/23/2022	2.4%	-2.8%	18.3%
11/9/2021	-0.1%	-1.8%	-26.1%
8/4/2021	-11.4%	-9.1%	-11.8%
5/11/2021	-18.5%	0.0%	37.3%
3/2/2021	-6.7%	-15.3%	-15.7%
11/12/2020	-3.3%	10.2%	58.2%
8/12/2020	-2.3%	1.7%	-17.4%
SUMMARY STATS
# Positive	9	12	10
# Negative	11	8	10
Median Positive	6.6%	15.3%	28.4%
Median Negative	-6.7%	-12.2%	-19.7%
Max Positive	47.0%	56.2%	176.3%
Max Negative	-27.7%	-31.4%	-37.7%

SEC Filings

Expand for More

Report Date	Filing Date	Filing
6302025	8052025	10-Q 6/30/2025
3312025	5062025	10-Q 3/31/2025
12312024	2262025	10-K 12/31/2024
9302024	10312024	10-Q 9/30/2024
6302024	7312024	10-Q 6/30/2024
3312024	5012024	10-Q 3/31/2024
12312023	2282024	10-K 12/31/2023
9302023	11032023	10-Q 9/30/2023
6302023	8042023	10-Q 6/30/2023
3312023	5052023	10-Q 3/31/2023
12312022	3032023	10-K 12/31/2022
9302022	11092022	10-Q 9/30/2022
6302022	8092022	10-Q 6/30/2022
3312022	5102022	10-Q 3/31/2022
12312021	3012022	10-K 12/31/2021
9302021	11092021	10-Q 9/30/2021

Insider Activity

Expand for More

	Owner	Title	Filing Date	Action	Price	Shares	Transacted Value	Value of Held Shares	Form
0	Peters John Sheldon	Chief Insurance Officer	6052025	Sell	35.25	1,494	52,664	3,740,554	Form
1	BIXBY TIMOTHY E	Chief Financial Officer	6052025	Sell	35.25	1,916	67,539	9,284,603	Form
2	Prosor Maya	Chief Business Officer	6052025	Sell	35.25	252	8,883	285,772	Form
3	SoftBank Group Capital Ltd		5142025	Sell	31.92	177,762	5,673,594	249,620,048	Form
4	SoftBank Group Capital Ltd		5122025	Sell	30.87	79,024	2,439,408	274,478,400	Form

Collapse to Preview

	Owner	Title	Filing Date	Action	Price	Shares	Transacted Value	Value of Held Shares	Form
0	Peters John Sheldon	Chief Insurance Officer	6052025	Sell	35.25	1,494	52,664	3,740,554	Form
1	BIXBY TIMOTHY E	Chief Financial Officer	6052025	Sell	35.25	1,916	67,539	9,284,603	Form
2	Prosor Maya	Chief Business Officer	6052025	Sell	35.25	252	8,883	285,772	Form
3	SoftBank Group Capital Ltd		5142025	Sell	31.92	177,762	5,673,594	249,620,048	Form
4	SoftBank Group Capital Ltd		5122025	Sell	30.87	79,024	2,439,408	274,478,400	Form
5	SoftBank Group Capital Ltd		5092025	Sell	30.66	146,383	4,488,249	280,254,479	Form
6	SoftBank Group Capital Ltd		5072025	Sell	30.27	398,215	12,054,685	291,147,180	Form
7	SoftBank Group Capital Ltd		5062025	Sell	30.17	422,177	12,738,009	302,204,272	Form
8	SoftBank Group Capital Ltd		5012025	Sell	30.01	13,815	414,534	313,208,503	Form
9	SoftBank Group Capital Ltd		4302025	Sell	30.00	500	15,000	313,559,280	Form
10	SoftBank Group Capital Ltd		3282025	Sell	37.22	42,160	1,569,301	389,067,288	Form
11	SoftBank Group Capital Ltd		3262025	Sell	36.90	85,132	3,141,660	391,695,603	Form
12	BIXBY TIMOTHY E	Chief Financial Officer	3062025	Sell	33.79	6,243	210,951	8,964,791	Form
13	Peters John Sheldon	Chief Insurance Officer	3062025	Sell	33.79	1,899	64,167	2,960,308	Form
14	Prosor Maya	Chief Business Officer	3062025	Sell	33.79	325	10,982	282,451	Form
15	Peters John Sheldon	Chief Insurance Officer	12102024	Sell	45.50	1,790	81,445	4,026,432	Form
16	Prosor Maya	Chief Business Officer	12102024	Sell	45.50	304	13,832	395,122	Form
17	SoftBank Group Capital Ltd		12202024	Sell	43.02	7,067	304,052	460,324,994	Form
18	SoftBank Group Capital Ltd		12182024	Sell	44.37	388,306	17,230,807	514,523,470	Form
19	Eisenberg Michael A		12172024	Sell	40.15	12,000	481,800	3,801,000	Form
20	Prosor Maya	Chief Business Officer	11252024	Sell	50.00	30,000	1,500,000	1,464,300	Form
21	Angelidis-Smith Maria		11132024	Buy	27.42	18,512	507,599	507,599	Form
22	Prosor Maya	Chief Business Officer	11132024	Sell	30.00	20,000	600,000	1,778,580	Form
23	BIXBY TIMOTHY E	Chief Financial Officer	9112024	Sell	18.24	2,050	37,392	4,953,108	Form
24	Peters John Sheldon	Chief Insurance Officer	9062024	Sell	18.84	1,547	29,145	1,700,932	Form
25	Prosor Maya	Chief Business Officer	9062024	Sell	18.84	263	4,955	169,334	Form

Industry Resources

Financials Resources

Federal Reserve Economic Data

External Quote Links

0	Y Finance	Barrons
1	TradingView	Morningstar
2	SeekingAlpha	ValueLine
3	Motley Fool	Robinhood
4	CNBC	Etrade
5	MarketWatch	Unusual Whales
6	YCharts	Perplexity Finance
7	FinViz

Prefer one of these to Trefis? Tell us why.

	2020	2021	2022	2023	2024	2025	Total [1]
Returns
LMND Return	-	-66%	-68%	18%	127%	52%	-57%
Peers Return	6%	20%	32%	8%	40%	4%	163%
S&P 500 Return	16%	27%	-19%	24%	23%	12%	104%
Monthly Win Rates [3]
LMND Win Rate	80%	25%	42%	42%	58%	50%
Peers Win Rate	62%	55%	60%	62%	70%	55%
S&P 500 Win Rate	58%	75%	42%	67%	75%	62%
Max Drawdowns [4]
LMND Max Drawdown	-	-68%	-69%	-23%	-11%	-32%
Peers Max Drawdown	-40%	-5%	-3%	-16%	-0%	-6%
S&P 500 Max Drawdown	-31%	-1%	-25%	-1%	-2%	-15%

Lemonade (LMND)

Market Price (9/18/2025): $56.54 | Market Cap: $4.2 BilSector: Financials | Industry: Property & Casualty Insurance

Lemonade (LMND)

Market Price (9/18/2025): $56.54Market Cap: $4.2 BilSector: FinancialsIndustry: Property & Casualty Insurance

Investment Highlights

Market Valuation

Stock Price Chart

Market Cap Chart

Business Description

Price Returns Compared

Interactive Breakdown

Better Bets than Lemonade (LMND)

Latest Trefis Analyses

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

1 Month Top Gainers

1 Month Top Losers

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Lemonade

Financials

Growth & Margins

Valuation

Returns

Comparison Analyses

FDIC Bank Data

Bank Capital

Bank Deposits

Bank Assets

Bank Loans

Financials

Segment Financials

Price Behavior

Short Interest

Returns Analyses

Earnings Returns History

SEC Filings

Insider Activity

Industry Resources

External Quote Links

Market Price (9/18/2025): $56.54 | Market Cap: $4.2 Bil
Sector: Financials | Industry: Property & Casualty Insurance

Market Price (9/18/2025): $56.54
Market Cap: $4.2 Bil
Sector: Financials
Industry: Property & Casualty Insurance